Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free BIAFW Stock Alerts

bioAffinity Technologies (BIAFW) Competitors

bioAffinity Technologies logo
$0.07 -0.02 (-21.99%)
As of 08/4/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

BIAFW vs. ALVOW, APLMW, ARAV, BIVIW, and CDIOW

Should you buy bioAffinity Technologies stock or one of its competitors? MarketBeat compares bioAffinity Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with bioAffinity Technologies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does bioAffinity Technologies compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$559.42MN/AN/AN/AN/A
bioAffinity Technologies$5.61MN/AN/AN/AN/A

In the previous week, Alvotech had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for bioAffinity Technologies. Alvotech's average media sentiment score of 0.67 beat bioAffinity Technologies' score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
bioAffinity Technologies Neutral

Summary

Alvotech beats bioAffinity Technologies on 3 of the 3 factors compared between the two stocks.

How does bioAffinity Technologies compare to Apollomics?

Apollomics (NASDAQ:APLMW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
bioAffinity Technologies$5.61MN/AN/AN/AN/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled bioAffinity Technologies'average media sentiment score.

Company Overall Sentiment
Apollomics Neutral
bioAffinity Technologies Neutral

Summary

Apollomics beats bioAffinity Technologies on 1 of the 1 factors compared between the two stocks.

How does bioAffinity Technologies compare to Aravive?

bioAffinity Technologies (NASDAQ:BIAFW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Aravive N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.61MN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, bioAffinity Technologies' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
bioAffinity Technologies Neutral
Aravive Neutral

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Aravive beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does bioAffinity Technologies compare to BioVie?

bioAffinity Technologies (NASDAQ:BIAFW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

In the previous week, bioAffinity Technologies' average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
bioAffinity Technologies Neutral
BioVie Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.61MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
BioVie N/A N/A N/A

Summary

bioAffinity Technologies beats BioVie on 1 of the 1 factors compared between the two stocks.

How does bioAffinity Technologies compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends.

In the previous week, Cardio Diagnostics had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for bioAffinity Technologies. Cardio Diagnostics' average media sentiment score of 0.98 beat bioAffinity Technologies' score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
bioAffinity Technologies Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
bioAffinity Technologies$5.61MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

Summary

Cardio Diagnostics beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

Get bioAffinity Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIAFW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIAFW vs. The Competition

Export
MetricbioAffinity TechnologiesBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.52B$6.83B$12.76B
Dividend YieldN/A3.77%2.59%10.01%
P/E RatioN/A7.32279.1525.53
Price / SalesN/A1,296.62595.5892.32
Price / CashN/A103.4472.1149.39
Price / BookN/A17.3613.066.11
Net IncomeN/A-$12.52M$3.48B$347.58M
7 Day PerformanceN/A3.69%3.40%4.91%
1 Month PerformanceN/A-5.34%-2.79%-2.06%
1 Year PerformanceN/A49.49%73.10%21.03%

bioAffinity Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIAFW
bioAffinity Technologies
N/A$0.07
-30.6%		N/A-50.0%$0.00$5.61MN/A10
ALVOW
Alvotech
N/A$0.15
flat		N/A-90.6%$0.00$559.42MN/A4
APLMW
Apollomics
N/A$0.02
+10.1%		N/A-26.8%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIVIW
BioVie
N/A$0.38
-2.6%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BIAFW) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...
SmartAsset | Sponsoredtc pixel